Skip to main content

Table 3 Unadjusted/multivariable-adjusted odds ratios of perioperative complicationsa

From: The impact of long-term aspirin use on the patients undergoing shoulder arthroplasty

Perioperative complication

Whole non-L-AU as controls

Matched non-L-AU as controls

Unadjusted OR (uOR)

(Wad 95%CI)

p value

Adjusted OR (aOR)

(Wad 95%CI)

p value

Any complicationb

0.871

0.825–0.920

 < 0.001

0.991

0.942–1.042

0.719

Blood transfusion

1.465

1.322–1.632

 < 0.001

1.339

1.191–1.505

 < 0.001

Periprosthetic joint infection (PJI)

1.117

0.913–1.367

0.281

0.933

0.721–1.208

0.598

Dislocation of prosthetic join

1.100

0.963–1.256

0.161

1.012

0.851–1.203

0.894

Hemorrhage/seroma/hematoma

0.829

0.585–1.174

0.290

0.857

0.549–1.338

0.497

Urinary tract infection (UTI)

0.867

0.765–0.982

0.025

0.870

0.742–1.021

0.088

Acute renal failure (ARF)

1.000

0.889–1.126

0.996

1.292

1.115–1.496

0.001

Thrombocytopenia

1.048

0.911–1.205

0.511

1.105

0.917–1.333

0.294

Acute postoperative pain

1.110

1.020–1.207

0.015

1.117

0.998–1.250

0.054

Respiratory disease

1.043

0.832–1.308

0.717

0.946

0.706–1.267

0.710

Genitourinary disease

1.247

1.130–1.375

 < 0.001

1.349

1.209–1.506

 < 0.001

Pneumonia

0.950

0.747–1.209

0.678

0.836

0.618–1.133

0.248

Gastrointestinal complication

1.580

0.989–2.523

0.054

1.375

0.722–2.619

0.330

Convulsion

1.039

0.829–1.301

0.742

1.204

0.884–1.639

0.239

Deep venous thrombosis (DVT)

0.778

0.455–1.331

0.358

1.071

0.517–2.220

0.853

Wound infection

0.882

0.438–1.773

0.724

1.286

0.479–3.453

0.617

Pulmonary embolism (PE)

0.836

0.530–1.319

0.441

0.750

0.426–1.321

0.317

Acute myocardial infarction (AMI)

0.961

0.730–1.264

0.775

1.494

1.073–2.078

0.017

Peripheral vascular disease

0.659

0.605–0.718

 < 0.001

1.063

0.969–1.165

0.196

Postoperative delirium (POD)

1.103

0.900–1.351

0.346

0.932

0.718–1.209

0.595

Septicemia

0.671

0.394–1.143

0.139

1.071

0.517–2.220

0.853

Acute cerebrovascular disease (ACD)

0.630

0.537–0.740

 < 0.001

0.722

0.586–0.891

0.002

Cardiac arrest

0.943

0.500–1.779

0.856

0.611

0.288–1.294

0.194

Postoperative shock

0.514

0.185–1.426

0.193

0.400

0.125–1.275

0.109

Gastrointestinal bleeding (GI bleeding)

1.256

0.675–2.336

0.472

0.857

0.396–1.853

0.695

Stroke

1.875

1.605–2.190

 < 0.001

0.725

0.587–0.894

0.003

Prolonged length of stay (> 75th percentile)

0.889

0.857–0.923

 < 0.001

0.837

0.798–0.877

 < 0.001

Higher total cost (> 75th percentile)

1.009

0.977–1.041

0.600

0.968

0.928–1.009

0.128

  1. aL-AU: long-term aspirin use
  2. bAny complication: defined as at least one complication observed in Table 3 that occurred in a patient
Back to article page

Journal of Orthopaedic Surgery and Research

ISSN: 1749-799X